Il mercato delle terapie per le verruche è stato valutato 1.829,54 milioni di dollari nel 2021 e si stima che crescerà a un CAGR del 3,4% dal 2021 al 2028.
La crescita del mercato delle terapie per le verruche è attribuita all'aumento prevalenza delle infezioni da papillomavirus umano e recidiva delle verruche genitali e sviluppo di nuovi prodotti. Tuttavia, lo scenario diagnostico inadeguato nei paesi a basso reddito frena la crescita del mercato. Le verruche sono una crescita della pelle causata dal papillomavirus umano (HPV). Esistono più di 60 tipi di HPV e molti di questi tendono a causare verruche sulla pelle. Anche se i trattamenti topici potrebbero probabilmente risolvere il problema delle verruche in poche settimane con effetti collaterali minimi, potrebbero non essere sempre efficaci. Pertanto, la crioterapia con azoto liquido è un'opzione adatta per il trattamento, dove il tasso di guarigione è del 60-90% e un tasso di recidiva inferiore al 10-20%.
Negli Stati Uniti, la domanda di procedure di trattamento delle verruche si è ridotta a causa allo spostamento dell’attenzione su COVID-19. La pandemia ha causato il caos nelle catene di approvvigionamento globali, nei mercati di consumo e nelle economie nel loro insieme. Di conseguenza, le misure implementate dai governi di tutto il mondo hanno avuto un impatto negativo sulla crescita del mercato delle terapie per le verruche.
Approfondimenti sul mercato
L'aumento della prevalenza delle infezioni da papillomavirus umano e la recidiva delle verruche genitali alimentano la crescita del mercato terapeutico delle verruche
Le verruche sono causate da vari ceppi di papillomavirus umano (HPV) e diversi ceppi causano verruche in diverse parti del corpo. Le persone sane che entrano in contatto con le verruche possono contrarre l'infezione. Secondo i Centri per il controllo e la prevenzione delle malattie (CDC), nel 2018, circa il 20% della popolazione, ovvero circa 42,5 milioni di persone, negli Stati Uniti aveva infezioni a trasmissione sessuale (IST). Inoltre, prima della vaccinazione HPV, le verruche genitali colpivano ogni anno circa 340.000-360.000 donne e uomini negli Stati Uniti. Inoltre, il tasso di recidiva delle verruche genitali è elevato. Secondo il National Center for Biotechnology Information (NCBI), si prevede che circa il 30% dei casi totali di verruche a livello globale regrediranno entro i primi quattro mesi dall’infezione. Inoltre, le infezioni da HPV portano al cancro della cervice e il cancro della cervice è il quarto tumore più comune tra le donne a livello globale. Secondo l’Organizzazione Mondiale della Sanità (OMS), nel 2018 sono stati registrati circa 570.000 nuovi casi di cancro cervicale con elevata prevalenza nei paesi a basso reddito. Pertanto, un aumento della prevalenza delle infezioni da HPV, che porta a un aumento dei casi di verruche, e l'alto tasso di recidiva delle verruche stanno guidando la crescita del mercato delle terapie per le verruche.
Approfondimenti basati sul tipo
Basato sul tipo , il mercato delle terapie per le verruche è ulteriormente segmentato in verruche comuni, verruche genitali, verruche piane e altri. Il segmento delle verruche comuni detiene la quota maggiore del mercato. Tuttavia, si prevede che il segmento delle verruche genitali registrerà il CAGR più elevato nel periodo 2021-2028. Le verruche genitali si riferiscono a infezioni trasmesse sessualmente che di solito sono causate dall'HPV. La crescente prevalenza di malattie sessualmente trasmissibili e i crescenti sforzi di ricerca e sviluppo per sviluppare opzioni di trattamento delle verruche genitali stimolerebbero la crescita del mercato di questo segmento nei prossimi anni.
Approfondimenti basati sul trattamento
In base al trattamento, il mercato delle terapie per le verruche è ulteriormente segmentato in distruzione fisica, immunomodulazione e distruzione chimica. Il mercato della distruzione fisica è ulteriormente segmentato in crioterapia, rimozione chirurgica e trattamento laser. L'immunomodulazione è suddivisa in interferoni, retinoidi e zinco. Il segmento della distruzione chimica è ulteriormente suddiviso in bleomicina, cantaridina, acido salicilico e altri. Il segmento della distruzione fisica detiene la quota maggiore del mercato delle verruche terapeutiche e si prevede che registrerà il CAGR più elevato sul mercato durante il periodo di previsione.
Approfondimenti basati sull'utente finale
Basato sull'utente finale, le verruche Il mercato delle terapie è segmentato in ospedali, assistenza domiciliare, cliniche specializzate e altri. Il segmento ospedaliero detiene la quota di mercato maggiore. Tuttavia, si stima che il segmento dell’assistenza domiciliare registrerà il CAGR più elevato durante il periodo di previsione. La crescita di mercato prevista per questo segmento può essere attribuita al numero crescente di ospedali in tutto il mondo e al numero in rapida crescita di procedure chirurgiche.
< br>Approfondimenti strategici
Le aziende che operano nel mercato delle terapie per le verruche stanno adottando la strategia di innovazione dei prodotti per soddisfare le richieste in continua evoluzione dei clienti in tutto il mondo, il che consente loro anche di mantenere il proprio marchio nel mercato globale.
Mercato terapeutico delle verruche - per tipo
- Verruche comuni
- Verruche genitali
- Verruche piane
- Altro
Mercato terapeutico delle verruche - per trattamento
- Distruzione fisica
- Crioterapia
- Rimozione chirurgica
- Trattamento laser
- Immunomodulazione
- Interferoni
- Retinoidi
- Zinco
- Distruzione chimica
- < li>Bleomicina
- Cantaridina
- Acido salicilico
- Altri
Mercato terapeutico delle verruche – per Utente finale
- Ospedali
- Assistenza domiciliare
- Cliniche specializzate
- Altro
Mercato terapeutico delle verruche: per area geografica
- Nord America
- Stati Uniti
- Canada
- Messico
< li>Europa - Francia
- Germania
- Italia
- Regno Unito
- Spagna
- Resto dell'Europa
- Asia Pacifico (APAC)
- Cina
- India
- Corea del Sud
- Giappone
- Australia
- Resto dell'area APAC
- Medio Oriente e Africa (MEA)
- Sud Africa
- Arabia Saudita
- Emirati Arabi Uniti
- Resto del MEA
- America centrale e meridionale (SCAM )
- Brasile
- Argentina
- Resto di SCAM
Profili aziendali
- Bausch Health Companies Inc.
- Nielsen BioSciences, Inc.
- Euro Vital Pharma GmbH
- Cipla Inc .
- Koninklijke Utermöhlen NV
- Novan, Inc.
- Scholl's Wellness Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Verrica Pharmaceuticals Inc.
- GlaxoSmithKline plc.
- AIM ImmunoTech Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Warts are skin growth caused by the human papillomavirus (HPV). There are more than 60 types of HPV, some of which tend to cause warts on the skin. Topical treatments could probably resolve the issue of warts in a few weeks with minimal side effects. Topical treatment of may not be effective all the time. Hence, cryotherapy with liquid nitrogen is a suitable option for treatment, where cure rate is 60% to 90% with less than 20% to 10% recurrence rate.
The factors that are driving growth of the market are rising prevalence of human papillomavirus infections and recurrence of genital warts and new product developments.
Various companies have made organic growth strategies in the warts therapeutics market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Nielsen BioSciences, Inc, TEVA PHARMACEUTICAL INDUSTRIES LTD amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.
North America dominates the global warts therapeutics market due to factors such as rising prevalence of HPV, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.
The physical destruction segment is growing at the highest CAGR owing to availability of diagnostic devices and ease offered by these devices for diagnosis of various disorders.
Asia Pacific is expected to be the fastest growing region in the warts therapeutics market. The growth of the market in this region is primarily due to supportive government initiatives and research in the field of HPV infection.
The List of Companies - Warts Therapeutics Market
- Bausch Health Companies Inc.
- Nielsen BioSciences, Inc.
- Euro Vital Pharma GmbH
- Cipla Inc.
- Koninklijke Utermöhlen NV
- Novan, Inc.
- Scholl's Wellness Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Verrica Pharmaceuticals Inc.
- GlaxoSmithKline plc.
- AIM ImmunoTech Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Aug 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Aug 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Aug 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)